Monika Ferlitsch

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. doi request reprint Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test
    Monika Ferlitsch
    Quality Assurance Working Group, Austrian Society of Gastroenterology and Hepatology, Freyung 6, 1010, Vienna, Austria
    Med Oncol 31:151. 2014
  2. doi request reprint Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy
    Monika Ferlitsch
    Quality Assurance Working Group, Austrian Society for Gastroenterology and Hepatology, Vienna, Austria
    JAMA 306:1352-8. 2011
  3. doi request reprint Sedation in screening colonoscopy: impact on quality indicators and complications
    Christina Bannert
    Quality Assurance Working Group of Austrian Society for Gastroenterology and Hepatology, Vienna, Austria
    Am J Gastroenterol 107:1837-48. 2012
  4. doi request reprint Forceps versus snare polypectomies in colorectal cancer screening: are we adhering to the guidelines?
    Martha Britto-Arias
    Department of Gastroenterology and Hepatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria
    Endoscopy 47:898-902. 2015
  5. doi request reprint Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient
    Arnulf Ferlitsch
    Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Liver Int 35:2115-20. 2015
  6. doi request reprint High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or setting
    Karin Kozbial
    Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Endoscopy 47:207-16. 2015
  7. doi request reprint A greater proportion of liver transplant candidates have colorectal neoplasia than in the healthy screening population
    Philip Jeschek
    Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria Quality Assurance Working Group of the Austrian Society of Gastroenterology and Hepatology, Vienna, Austria
    Clin Gastroenterol Hepatol 13:956-62. 2015
  8. doi request reprint Endoscopists with low adenoma detection rates benefit from high-definition endoscopy
    Elisabeth Waldmann
    Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Surg Endosc 29:466-73. 2015
  9. doi request reprint Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine
    Simona Bota
    Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Ultrasound Med Biol 41:2340-9. 2015
  10. doi request reprint von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis
    Monika Ferlitsch
    Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Hepatology 56:1439-47. 2012

Collaborators

Detail Information

Publications14

  1. doi request reprint Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test
    Monika Ferlitsch
    Quality Assurance Working Group, Austrian Society of Gastroenterology and Hepatology, Freyung 6, 1010, Vienna, Austria
    Med Oncol 31:151. 2014
    ..9 (1.8-2.1) and 1.8 (1.6-2), respectively (p < 0.001). Male sex is a stronger predictor for colorectal adenoma and advanced adenoma than positive FOBT. These results should be taken into account analyzing FOBT-based screening programs...
  2. doi request reprint Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy
    Monika Ferlitsch
    Quality Assurance Working Group, Austrian Society for Gastroenterology and Hepatology, Vienna, Austria
    JAMA 306:1352-8. 2011
    ..Although some studies have shown that men are at greater age-specific risk for advanced colorectal neoplasia than women, the age for referring patients to screening colonoscopy is independent of sex and usually recommended to be 50 years...
  3. doi request reprint Sedation in screening colonoscopy: impact on quality indicators and complications
    Christina Bannert
    Quality Assurance Working Group of Austrian Society for Gastroenterology and Hepatology, Vienna, Austria
    Am J Gastroenterol 107:1837-48. 2012
    ..The objective of this study is to assess the impact of sedation on quality indicators, including CIR and ADR, according to sex...
  4. doi request reprint Forceps versus snare polypectomies in colorectal cancer screening: are we adhering to the guidelines?
    Martha Britto-Arias
    Department of Gastroenterology and Hepatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria
    Endoscopy 47:898-902. 2015
    ..The aim of this study was to investigate polypectomy technique according to lesion size and shape, and to assess adherence of endoscopists enrolled in the national quality assurance program to the European guidelines...
  5. doi request reprint Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient
    Arnulf Ferlitsch
    Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Liver Int 35:2115-20. 2015
    ..The aim of the study was to evaluate the clinical applicability of a novel balloon (NC) occlusion catheter specifically designed for HVPG measurement...
  6. doi request reprint High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or setting
    Karin Kozbial
    Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Endoscopy 47:207-16. 2015
    ..The aim of this study was to investigate the impact of these two factors on quality parameters for screening colonoscopy in a quality-assured screening program...
  7. doi request reprint A greater proportion of liver transplant candidates have colorectal neoplasia than in the healthy screening population
    Philip Jeschek
    Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria Quality Assurance Working Group of the Austrian Society of Gastroenterology and Hepatology, Vienna, Austria
    Clin Gastroenterol Hepatol 13:956-62. 2015
    ..We investigated whether cirrhosis is a risk factor for colorectal neoplasia by analyzing colonoscopy findings from 2 cohorts of patients awaiting liver transplantation...
  8. doi request reprint Endoscopists with low adenoma detection rates benefit from high-definition endoscopy
    Elisabeth Waldmann
    Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Surg Endosc 29:466-73. 2015
    ..We aimed to investigate whether detection rates of individual endoscopists increase within 1 year before and 1 year after the switch from standard to HD endoscopy...
  9. doi request reprint Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine
    Simona Bota
    Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Ultrasound Med Biol 41:2340-9. 2015
    ..915), respectively. In conclusion, 2-D SWE can be used to obtain reliable liver stiffness measurements in almost all patients and performs very well in predicting the presence of liver cirrhosis. ..
  10. doi request reprint von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis
    Monika Ferlitsch
    Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Hepatology 56:1439-47. 2012
    ..vWF-Ag equals Model for End-Stage Liver Disease (MELD) in mortality prediction (area under the curve [AUC] = 0.71 for vWF-Ag versus AUC = 0.65 for MELD; P = 0.2)...
  11. doi request reprint Tumor and Patient Characteristics of Individuals with Mismatch Repair Deficient Colorectal Cancer
    Elisabeth Waldmann
    Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    Digestion 91:286-93. 2015
    ..To investigate tumor and patient characteristics of individuals with mismatch repair (MMR)-deficient colorectal carcinomas...
  12. doi request reprint Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II)
    Markus Peck-Radosavljevic
    Klinische Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Wien Klin Wochenschr 125:200-19. 2013
    ..The Billroth II-Guidelines on the definitions and treatment of portal hypertension and its complications take into account the developments of the last 7 years, including the Baveno-V update and several key publications...
  13. doi request reprint Efficacy and safety of bovine activated factors IIa/VIIa/IXa/Xa in patients with active gastrointestinal bleeding: a proof of concept study
    Arnulf Ferlitsch
    Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
    Endoscopy 48:380-4. 2016
    ..Our aim was to assess the efficacy and safety of endoscopic hemostasis with a liquid combination of bovine activated factors IIa/VIIa/IXa/Xa (SeraSeal)...
  14. doi request reprint How can screening colonoscopy be optimized?
    Elisabeth Waldmann
    Division of Gastroenterology and Hepatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria
    Dig Dis 33:19-27. 2015
    ..Alternative screening tools such as CT colonography, barium enema CT and multitarget stool DNA tests have not been established as routine screening tools to date...